Analyst Upgrades – Momenta Pharmaceuticals (NASDAQ:MNTA) Stock Gets Upgraded By Stifel Nicolaus from Hold to Buy

ME Staff
-
0

Analyst Ratings For Momenta Pharmaceuticals (NASDAQ:MNTA)

Today, Momenta Pharmaceuticals (NASDAQ:MNTA) stock received an upgrade by Stifel Nicolaus from Hold to Buy with a price target of $21.00.

Some recent analyst ratings include

  • 2/22/2018-Stifel Nicolaus Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 10/6/2017-Robert W. Baird was Downgraded by analysts at Robert W. Baird from a “Buy ” rating to a ” Hold” rating. They now have a $15.00 price target on the stock, up previously from $22.00 .
  • 10/5/2017-JPMorgan Chase & Co. Reiterated Rating of Hold.
  • 10/5/2017-Goldman Sachs Group Reiterated Rating of Neutral.
  • 10/4/2017-Barclays Reiterated Rating of Equal Weight.

Recent Insider Trading Activity For Momenta Pharmaceuticals (NASDAQ:MNTA)
Momenta Pharmaceuticals (NASDAQ:MNTA) has insider ownership of 4.40% and institutional ownership of 95.43%.

  • On 2/14/2018 Bruce Leicher, SVP, sold 4,948 with an average share price of $15.22 per share and the total transaction amounting to $75,308.56.
  • On 2/14/2018 Craig A Wheeler, CEO, sold 18,648 with an average share price of $16.14 per share and the total transaction amounting to $300,978.72.
  • On 2/14/2018 Ganesh Venkataraman Kaundinya, COO, sold 4,986 with an average share price of $15.23 per share and the total transaction amounting to $75,936.78.
  • On 2/14/2018 Scott M. Storer, CFO, sold 3,972 with an average share price of $15.16 per share and the total transaction amounting to $60,215.52.
  • On 2/12/2018 Bruce Leicher, SVP, sold 309 with an average share price of $16.20 per share and the total transaction amounting to $5,005.80.
  • On 2/12/2018 Craig A Wheeler, CEO, sold 1,773 with an average share price of $16.18 per share and the total transaction amounting to $28,687.14.
  • On 2/12/2018 Ganesh Venkataraman Kaundinya, COO, sold 341 with an average share price of $16.20 per share and the total transaction amounting to $5,524.20.

Recent Trading Activity for Momenta Pharmaceuticals (NASDAQ:MNTA)
Shares of Momenta Pharmaceuticals closed the previous trading session at 17.00 up +0.65 3.98% with 17.0 shares trading hands.